Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT

Market Cap	49.86M 57M 45.99M 42.48M 80.6M 5.44B 81.95M 549M 216M 2.68B 214M 209M 9.21B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	57.71M 65.98M 53.23M 49.17M 93.29M 6.29B 94.86M 636M 250M 3.1B 248M 242M 10.66B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
05-11	Theraclion raises nearly 6 million euros via units with warrants

07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
06-04	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU
06-01	Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented	BU

07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
06-19	Les puces américaines en weekend prolongé
06-19	Claude Lenoir nommé président par intérim de Theraclion

THERACLION N Stock Euronext Paris

Stocks

FR0010120402

Advanced Medical Equipment & Technology

Valuation: THERACLION N

Latest news : THERACLION N

Press Releases: THERACLION N

News in other languages: THERACLION N

Managers and Directors: THERACLION N

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Jeremie Anquez CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	01/02/2018
Ari Kellen BRD	Director/Board Member	-	13/02/2019
Shawn Langer BRD	Director/Board Member	-	13/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	+0.45%	+0.69%	+21.20%	+1.50%	196B
INTUITIVE SURGICAL, INC.	-1.16%	-4.51%	-20.56%	+19.96%	144B
DANAHER CORPORATION	+1.57%	+0.57%	-2.83%	-16.25%	141B
BOSTON SCIENTIFIC CORPORATION	-0.49%	-0.82%	-56.62%	-14.64%	66.54B
EDWARDS LIFESCIENCES CORPORATION	+0.96%	-2.29%	+18.14%	-0.25%	53.09B
SIEMENS HEALTHINEERS AG	+0.61%	-1.09%	-24.93%	-30.81%	44.12B
AGILENT TECHNOLOGIES, INC.	+0.52%	+2.75%	+8.93%	+13.34%	37.93B
WATERS CORPORATION	-0.19%	-0.75%	+6.66%	+42.84%	36.96B
GE HEALTHCARE TECHNOLOGIES INC.	0.00%	-1.32%	-13.88%	-20.38%	29.43B
Average	+0.25%	-0.84%	-7.10%	-0.52%	83.21B
Weighted average by Cap.	+0.27%	-0.96%	-3.92%	+0.03%

	2024	2025
Net sales	830K 949K 766K 707K 1.34M 90.52M 1.36M 9.15M 3.59M 44.59M 3.56M 3.49M 153M	652K 745K 601K 555K 1.05M 71.09M 1.07M 7.19M 2.82M 35.02M 2.8M 2.74M 120M
Net income	-5.76M -6.58M -5.31M -4.9M -9.31M -628M -9.46M -63.45M -24.92M -309M -24.71M -24.18M -1.06B	-5.69M -6.51M -5.25M -4.85M -9.2M -620M -9.35M -62.71M -24.63M -306M -24.42M -23.89M -1.05B
Net Debt	3.41M 3.9M 3.15M 2.91M 5.51M 372M 5.61M 37.59M 14.76M 183M 14.64M 14.32M 630M	7.85M 8.98M 7.24M 6.69M 12.69M 856M 12.91M 86.54M 33.98M 422M 33.71M 32.97M 1.45B

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-